Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-389,200
Closed -$11.8M 5727
2025
Q4
$11.8M Sell
389,200
-46,600
-11% -$1.14M ﹤0.01% 1114
2025
Q3
$8.63M Buy
435,800
+201,700
+86% +$4.22M ﹤0.01% 1235
2025
Q2
$5.84M Sell
234,100
-33,900
-13% -$764K ﹤0.01% 1298
2025
Q1
$6.28M Buy
268,000
+96,200
+56% +$2.79M ﹤0.01% 1107
2024
Q4
$4.8M Sell
171,800
-16,100
-9% -$432K ﹤0.01% 1256
2024
Q3
$3.83M Buy
187,900
+7,100
+4% +$159K ﹤0.01% 1266
2024
Q2
$5.34M Buy
180,800
+3,400
+2% +$97.7K ﹤0.01% 1037
2024
Q1
$5.41M Buy
+177,400
New +$5.01M ﹤0.01% 936

Other funds holding CFLT

IMC Chicago's CFLT Position: Q1 2026 in Review

IMC Chicago sold out of Confluent (CFLT) in Q1 2026, closing a stake of 169,606 shares — an estimated $5.13M sold.

IMC Chicago first reported a position in CFLT in Q1 2024 and held it in 7 quarters. The position peaked at $5.13M in Q4 2025. 4 funds tracked by Wall St. Rank hold CFLT as of Q1 2026.

  • IMC Chicago reported no remaining Confluent position as of Q1 2026 after selling out during the quarter.
  • IMC Chicago sold 169,606 Confluent shares in Q1 2026, an estimated $5.13M.
  • IMC Chicago first reported a position in Confluent in Q1 2024 and held it in 7 quarters.
  • IMC Chicago's Confluent position peaked at $5.13M in Q4 2025.
  • 4 funds tracked by Wall St. Rank held Confluent as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.